Product Theater: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis
Topics: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis
Faculty: Andrew Blauvelt, MD, MBA
This Product Theater, sponsored by Regeneron Pharmaceuticals / Sonofi Genzyme, is from the SDPA Annual Summer Dermatology Conference 2017.
